Does the Incremental Shuttle Walk Test Predict the Development of a Hospital Acquired Pneumonia in Patients Undergoing Elective Oesophagectomy: A Prospective Cohort Study
- Conditions
- Oesophageal Cancer
- Registration Number
- NCT04440124
- Lead Sponsor
- University Hospital Birmingham NHS Foundation Trust
- Brief Summary
The purpose of this study was to assess the predictive value of the incremental shuttle walk test on rates of hospital acquired pneumonia for patients undergoing oesophagectomy.
- Detailed Description
Field tests to objectively measure functional capacity are becoming of greater importance when looking to assess an individual's fitness for surgery. One such field test is the incremental shuttle walk test (ISWT). An externally paced, maximal excursion test, the ISWT is a simple and easily reproducible test that is widely used within cardiac and pulmonary populations and shown to correlate well with Vo2 mas on a cardiopulmonary exercise test. Previous studies looking at the benefit of the ISWT in predicting post-operative outcomes within the oesophagastric population have demonstrated that walking less than 350 meters has been associated with significantly higher rates of mortality at 30 days and 3 years. No correlation between ISWT and postoperative respiratory complications in this surgical population has been previously reported.
This study aims to assess whether walking \<350 meters on an ISWT predicts the development of hospital acquired pneumonias following an elective oesophagectomy
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 121
- Consecutive patients with a diagnosis of oesophagogastric cancer listed for an elective oesophagectomy at a large UK tertiary hospital
- Patients who were unable to complete the walking test
- patients deemed not fit for surgery
- patients with a significant neurological event peri or post operatively
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hospital acquired pneumonia during hospital stay, on average 14 days The incidence of hospital acquired pneumonia as defined by the US centres for Disease Control
- Secondary Outcome Measures
Name Time Method 90 day Mortality 90 days following date of surgery Mortality rates 90 days post operatively
30 day Mortality 30 days after date of surgery Mortality rates 30 days post operatively
Trial Locations
- Locations (1)
UHB NHS Foundation Trust
🇬🇧Birmingham, United Kingdom
UHB NHS Foundation Trust🇬🇧Birmingham, United Kingdom